دورية أكاديمية

Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents.

التفاصيل البيبلوغرافية
العنوان: Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents.
المؤلفون: Sahu B; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, G.T Road, Moga, Punjab 142001, India., Bhatia R; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, G.T Road, Moga, Punjab 142001, India., Kaur D; Department of Pharmacology, ISF College of Pharmacy, Ghal Kalan, G.T Road, Moga, Punjab 142001, India., Choudhary D; Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401 Punjab, India., Rawat R; School of Health Sciences & Technology, UPES University, Dehradun 248007, India., Sharma S; Department of Biotechnology, Bennett University, Greater Noida 201310, India., Kumar B; Department of Pharmaceutical Sciences, HNB Garhwal University, Chauras Campus, Srinagar, Garhwal, Uttarakhand 246174, India; Department of Chemistry, Graphic Era (Deemed to be University), Dehradun, Uttarakhand 248002, India. Electronic address: bhupinderkumar25@gmail.com.
المصدر: Bioorganic chemistry [Bioorg Chem] 2023 Jul; Vol. 136, pp. 106544. Date of Electronic Publication: 2023 Apr 20.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Elsevier
Original Publication: New York, London, Academic Press.
مواضيع طبية MeSH: Monoamine Oxidase Inhibitors*/chemistry , Neuroblastoma*, Humans ; Molecular Docking Simulation ; Structure-Activity Relationship ; Antidepressive Agents/chemistry ; Monoamine Oxidase/metabolism ; Piperazine/pharmacology ; Molecular Structure
مستخلص: Piperazine derivatives have been of great interest to medicinal chemists in the development of antidepressant drugs due to their distinct molecular and structural features along with their pharmacological profile. In this study, we have designed and synthesized a series of 10 compounds of piperazine clubbed oxadiazole derivatives (5a-j) and screened for their MAO inhibitory activity. Compound 5f and 5 g were found to be the most potent MAO-A inhibitors of the series with IC 50 values of 0.96 ± 0.04 µM µM and 0.81 ± 0.03 µM, respectively with a selectivity index of 18-folds and 9-folds over MAO-B isoform. The compounds were found to be reversible inhibitors of MAO-A with no cytotoxicity against SH-SY5Y neuronal cells. The compounds also displayed good antioxidant activity. Further, in vivo TST studies revealed that both the compounds 5f and 5 g possessed good anti-depressant-like activity and reduced the immobility time significantly although were found inactive in FST studies. The molecular docking studies revealed that both compounds fit well at the active site of MAO-A enzyme as similar to clorgyline and form a stable complex. The results were confirmed via molecular dynamic studies which demonstrate the stable complex formation between MAO-A and 5f & 5 g. The appropriate drug-like characteristics with favourable ADMET profile, these molecules presented this piperazine clubbed oxadiazole structural framework as a key pharmacophore for the development of new antidepressant molecules along with strong candidature for further clinical investigations.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
فهرسة مساهمة: Keywords: Antidepressant activity; Antioxidant; Benzylpiperazine; FST and TST; MAO inhibitors; Phenylpiperazine
المشرفين على المادة: 0 (Monoamine Oxidase Inhibitors)
0 (Antidepressive Agents)
EC 1.4.3.4 (Monoamine Oxidase)
1RTM4PAL0V (Piperazine)
تواريخ الأحداث: Date Created: 20230428 Date Completed: 20230529 Latest Revision: 20230531
رمز التحديث: 20240628
DOI: 10.1016/j.bioorg.2023.106544
PMID: 37116324
قاعدة البيانات: MEDLINE
الوصف
تدمد:1090-2120
DOI:10.1016/j.bioorg.2023.106544